Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

methocarbamol

methocarbamol
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Robaxin SOLUTION, INJECTABLE 100 mg/mL      
Robaxin TABLET, ORAL 500 mg      
Robaxin-750 TABLET, ORAL 750 mg      
VIEW MORE Centrally Acting Skeletal Muscle Relaxants
CLASS
122004
Comments:

Pharmacists may convert IV to PO on a 1 mg to 1 mg as below:

Ordered dose PO conversion
  • 1,000 mg IV every 8 hours
  • 1,000 mg PO every 6 hours

If insufficient muscle pain or spasm control and if methocarbamol IV was administer for < 3 days:

methocarbamol PO dose may be increased to 1,500 mg q6hr for up to 3 days

and then reduced to 1,500 mg q8hr or 1,000 mg q6hr

Updated: 23 Feb 2016 (methocarbamol tablet)

 

Last updated: May. 9, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved